Body Fluids in End-Stage Renal Disease: Statics and Dynamics

被引:15
|
作者
Kooman, Jeroen P. [1 ]
van der Sande, Frank M. [1 ]
机构
[1] Maastricht Univ, Med Ctr, Maastricht, Netherlands
关键词
Fluid overload; Hemodialysis; Bioimpedance spectroscopy; Relative blood volume; Absolute blood volume; Oxygen saturation; ENDOTHELIAL GLYCOCALYX; HEMODIALYSIS-PATIENTS; VOLUME OVERLOAD; PLASMA-VOLUME; BLOOD-VOLUME; MAINTENANCE HEMODIALYSIS; BIOIMPEDANCE ANALYSIS; SODIUM STORAGE; MORTALITY RISK; DIALYSIS;
D O I
10.1159/000494583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Abnormalities in fluid status in hemodialysis (HD) patients are highly prevalent and are related to adverse outcomes. Summary: The inherent discontinuity of the HD procedure in combination with an often compromised cardiovascular response is a major contributor to this phenomenon. In addition, systemic inflammation and endothelial dysfunction are related to extracellular fluid overload (FO). Underlying this relation may be factors such as hypoalbuminemia and an increased capillary permeability, leading to an altered fluid distribution between the blood volume (BV) and the interstitial fluid compartments, compromising fluid removal during dialysis. Indeed, whereas estimates of extracellular volume by bioimpedance spectroscopy are highly predictive of mortality, absolute BV assessed by the saline dilution technique was predictive of intra-dialytic morbidity. Changes in relative BV during HD are positively related to ultrafiltration rate (UFR) and, at least in some studies, negatively to FO. High UFR is also related to changes in central venous oxygen saturation (ScvO2), a marker for tissue perfusion. On the one hand, high UFR and more pronounced declines in ScvO2, but on the other hand, flat relative BV curves are also predictive of mortality; the relation between outcome which statics and dynamics of fluid status appears to be complex. Key Message: While technological developments enable the clinician to monitor statics and dynamics of fluid status and hemodynamics during HD in an accessible way, the role of technology-based interventions needs further study. (c) 2018 S. Karger AG, Basel
引用
收藏
页码:223 / 229
页数:7
相关论文
共 50 条
  • [41] Renal replacement treatment for end-stage renal disease
    Canaud, B
    Ryckelynck, JP
    Hourmant, MY
    PRESSE MEDICALE, 2005, 34 (16): : 1197 - 1199
  • [42] Implanted renal replacement for end-stage renal disease
    Roy, S.
    Goldman, K. G.
    Marchant, R. E.
    Zydney, A. L.
    Brown, D. L.
    Fleischman, A. J.
    Conlisk, A. T.
    Desai, T. A.
    Duffy, S.
    Humes, H. D.
    Fissell, W. H.
    PANMINERVA MEDICA, 2011, 53 (03) : 155 - 166
  • [43] spontaneous renal haemorrhage in end-stage renal disease
    Tonolini, Massimo
    Ierardi, Anna Maria
    Carrafiello, Gianpaolo
    INSIGHTS INTO IMAGING, 2015, 6 (06): : 693 - 695
  • [44] End-stage renal disease from renal metastases
    Ender, Matthias
    Cejna, Manfred
    Lhotta, Karl
    KIDNEY INTERNATIONAL, 2015, 87 (01) : 246 - 246
  • [45] Bioelectrical impedance analysis and assessment of body composition in end-stage renal disease
    Di Iorio, BR
    Bellizzi, V
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (09) : 1943 - 1944
  • [46] Predictors of end-stage renal disease and body mass index in a screened cohort
    Iseki, K
    Ikemiya, Y
    Fukiyama, K
    KIDNEY INTERNATIONAL, 1997, : S169 - S170
  • [47] Cardiovascular disease in end-stage renal disease patients
    Collins, AJ
    Li, SL
    Ma, JZ
    Herzog, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S26 - S29
  • [48] Homocysteinemia and vascular disease in end-stage renal disease
    Dennis, VW
    Robinson, K
    KIDNEY INTERNATIONAL, 1996, 50 : S11 - S17
  • [49] The epidemic of cardiovascular disease in end-stage renal disease
    Brenner, RM
    Wrone, EM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (03): : 365 - 369
  • [50] End-stage renal disease in patients with Fabry disease
    Obrador, GT
    Ojo, A
    Thadhani, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : S144 - S146